Company intelligence / Profile preview

Ranbaxy Nigeria

Lagos, Lagos, Nigeria

Ownership: Private
Employees: ~250
Development stage: Other

Overview

Ranbaxy Nigeria is a leading pharmaceutical company in Nigeria and a subsidiary of Sun Pharma. The company specializes in the manufacturing, marketing, and distribution of a wide range of generic pharmaceutical products, including anti-malarials, antibiotics, and analgesics. It operates a World Health Organization (WHO) pre-qualified manufacturing facility in Lagos, ensuring high-quality standards for the local and regional markets. Ranbaxy Nigeria plays a significant role in the Nigerian healthcare sector by providing affordable essential medicines. The company leverages its parent's global R&D and manufacturing expertise to serve the West African market.

Therapeutic areas: Infectious DiseasesGastroenterologyCardiovascularNeurologyEndocrinology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Ranbaxy Nigeria.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ranbaxy Nigeria.

Explore the full profile